BLC
GILD icon

Brown, Lisle/Cummings’s Gilead Sciences GILD Stock Holding History

Brown, Lisle/Cummings’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$172K Buy
1,365
+16
+1% +$2.11K 0.04% 246
2026
Q1 		$188K Hold
1,349
– – 0.05% 220
2025
Q4 		$166K Sell
1,349
-150
-10% -$18.2K 0.04% 230
2025
Q3 		$166K Hold
1,499
– – 0.04% 226
2025
Q2 		$166K Sell
1,499
-125
-8% -$13.3K 0.04% 230
2025
Q1 		$182K Buy
1,624
+49
+3% +$5.06K 0.05% 208
2024
Q4 		$145K Sell
1,575
-500
-24% -$45K 0.04% 234
2024
Q3 		$174K Sell
2,075
-766
-27% -$58.4K 0.05% 219
2024
Q2 		$195K Buy
2,841
+1
+0% +$67 0.06% 202
2024
Q1 		$208K Sell
2,840
-224
-7% -$17.2K 0.07% 193
2023
Q4 		$248K Sell
3,064
-149
-5% -$11.6K 0.09% 178
2023
Q3 		$241K Buy
3,213
+77
+2% +$5.92K 0.11% 166
2023
Q2 		$242K Sell
3,136
-1,349
-30% -$108K 0.11% 165
2023
Q1 		$372K Sell
4,485
-2,019
-31% -$167K 0.19% 122
2022
Q4 		$558K Buy
6,504
+181
+3% +$14.3K 0.3% 86
2022
Q3 		$390K Sell
6,323
-116
-2% -$7.32K 0.23% 105
2022
Q2 		$398K Sell
6,439
-417
-6% -$25.8K 0.22% 106
2022
Q1 		$408K Buy
6,856
+1,065
+18% +$68.1K 0.2% 114
2021
Q4 		$420K Buy
+5,791
New +$399K 0.21% 109

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown, Lisle/Cummings's GILD Position: Q2 2026 in Review

Brown, Lisle/Cummings increased its Gilead Sciences (GILD) stake by 1.2% in Q2 2026, buying an estimated $2.11K and bringing the position to 1,365 shares worth $172K. The position accounts for 0.04% of the portfolio, ranked #246.

Brown, Lisle/Cummings first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $558K in Q4 2022. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Brown, Lisle/Cummings held 1,365 shares of Gilead Sciences worth $172K as of Q2 2026.
  • Brown, Lisle/Cummings bought 16 Gilead Sciences shares in Q2 2026, an estimated $2.11K.
  • Gilead Sciences made up 0.04% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #246 holding.
  • Brown, Lisle/Cummings first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • Brown, Lisle/Cummings's Gilead Sciences position peaked at $558K in Q4 2022.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.